๐ŸŽ Black Friday: up to 50% off of annual plans
Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG ยท Real-Time Price ยท USD
39.29
-0.57 (-1.43%)
Nov 20, 2026, 4:00 PM EST - Market closed

COAG Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Operating Income
-99.9-70.12-50.38
Net Income
-93.47-63.91-48.71
Earnings Per Share
-4.72-67.56-51.49
EPS Growth
---

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Cash & Investments
430.24185.4988.33
Total Debt
0.971.271.89
Net Cash (Debt)
429.27184.2286.43
Net Cash Growth
396.65%113.13%-
Net Cash Per Share
21.68194.7391.37

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
Operating Cash Flow
-89.23-61.48-45.59
Capital Expenditures
-0.17-0.02-0.28
Free Cash Flow
-89.4-61.49-45.87
Free Cash Flow Growth
---